[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Identifieur interne : 000116 ( Main/Exploration ); précédent : 000115; suivant : 000117[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Auteurs : E. Redondo [Espagne] ; I. Rivero [Espagne] ; D A Vargas [Espagne] ; E. Mascar S [Espagne] ; J L Díaz-Maroto [Espagne] ; M. Linares [Espagne] ; J. Valdepérez [Espagne] ; A. Gil [Espagne] ; J. Molina [Espagne] ; I. Jimeno [Espagne] ; D. Oca A [Espagne] ; F. Martin N-Torres [Espagne]Source :
- Semergen [ 1578-8865 ] ; 2016.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Espagne (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Infections communautaires (prévention et contrôle), Jeune adulte (MeSH), Pneumonie à pneumocoques (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Saisons (MeSH), Sujet âgé (MeSH), Vaccination de masse (méthodes), Vaccins antigrippaux (administration et posologie), Vaccins antipneumococciques (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins antipneumococciques.
- méthodes : Vaccination de masse.
- prévention et contrôle : Grippe humaine, Infections communautaires, Pneumonie à pneumocoques, Pneumopathie virale.
- Adolescent, Adulte, Adulte d'âge moyen, Espagne, Humains, Jeune adulte, Saisons, Sujet âgé.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Community-Acquired Infections (prevention & control), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Mass Vaccination (methods), Middle Aged (MeSH), Pneumococcal Vaccines (administration & dosage), Pneumonia, Pneumococcal (prevention & control), Pneumonia, Viral (prevention & control), Seasons (MeSH), Spain (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Pneumococcal Vaccines.
- methods : Mass Vaccination.
- prevention & control : Community-Acquired Infections, Influenza, Human, Pneumonia, Pneumococcal, Pneumonia, Viral.
- Adolescent, Adult, Aged, Humans, Middle Aged, Seasons, Spain, Young Adult.
Abstract
INTRODUCTION
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults. The annual incidence of CAP in adults in Spain ranges from 3 to 14 cases per 1,000 inhabitants. Current clinical guidelines primarily focus on the therapeutic approach to CAP rather than its prevention. The aim of this study is to develop and propose a practical guide for CAP prevention through vaccination in Spain according to available vaccines and evidence.
METHODS
A literature review and expert opinion.
RESULTS
Pneumococcal and influenza vaccines are the main preventive tools available against CAP. Age, chronic diseases, and immunosuppression are risk factors for pneumonia, so these populations should be a priority for vaccination. In addition, influenza and pneumococcal vaccination is considered advisable in healthy adults under 60 years of age, and anyone with risk condition for CAP, irrespective of age. The influenza vaccine will be administered seasonally, while pneumococcal vaccination can be administered at any time of the year.
CONCLUSIONS
Vaccination against pneumococcus and influenza in adults can help to reduce the burden of CAP and its associated complications. The available evidence supports the priority indications set out in this guide, and it would be advisable to try to achieve a wide circulation and practical implementation of these recommendations.
DOI: 10.1016/j.semerg.2016.07.009
PubMed: 27641310
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].</title><author><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Coordinadora del Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Coordinadora del Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rivero, I" sort="Rivero, I" uniqKey="Rivero I" first="I" last="Rivero">I. Rivero</name><affiliation wicri:level="1"><nlm:affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña</wicri:regionArea><wicri:noRegion>A Coruña</wicri:noRegion></affiliation></author><author><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería</wicri:regionArea><wicri:noRegion>Almería</wicri:noRegion></affiliation></author><author><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Centro de Atención Primaria de Guadalajara, Guadalajara, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Atención Primaria de Guadalajara, Guadalajara</wicri:regionArea><wicri:noRegion>Guadalajara</wicri:noRegion></affiliation></author><author><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia y microbiólogo clínico, Miembro del Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia y microbiólogo clínico, Miembro del Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Valdeperez, J" sort="Valdeperez, J" uniqKey="Valdeperez J" first="J" last="Valdepérez">J. Valdepérez</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Centro de Salud Actur Sur, Zaragoza, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Salud Actur Sur, Zaragoza</wicri:regionArea><wicri:noRegion>Zaragoza</wicri:noRegion></affiliation></author><author><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><affiliation wicri:level="3"><nlm:affiliation>Especialista en Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Especialista en Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Atención Primaria Francia, Fuenlabrada, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Responsable Grupo de Trabajo Vacunas SEMG, Centro de Salud Isla de Oza, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Responsable Grupo de Trabajo Vacunas SEMG, Centro de Salud Isla de Oza, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Miembro del Grupo de Respiratorio SEMG, Centro de Salud Algeciras Norte, Algeciras, Cádiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Miembro del Grupo de Respiratorio SEMG, Centro de Salud Algeciras Norte, Algeciras, Cádiz</wicri:regionArea><wicri:noRegion>Cádiz</wicri:noRegion></affiliation></author><author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><affiliation wicri:level="1"><nlm:affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña</wicri:regionArea><wicri:noRegion>A Coruña</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27641310</idno><idno type="pmid">27641310</idno><idno type="doi">10.1016/j.semerg.2016.07.009</idno><idno type="wicri:Area/Main/Corpus">00117</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00117</idno><idno type="wicri:Area/Main/Curation">000117</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000117</idno><idno type="wicri:Area/Main/Exploration">000117</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].</title><author><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Coordinadora del Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Coordinadora del Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rivero, I" sort="Rivero, I" uniqKey="Rivero I" first="I" last="Rivero">I. Rivero</name><affiliation wicri:level="1"><nlm:affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña</wicri:regionArea><wicri:noRegion>A Coruña</wicri:noRegion></affiliation></author><author><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería</wicri:regionArea><wicri:noRegion>Almería</wicri:noRegion></affiliation></author><author><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Centro de Atención Primaria de Guadalajara, Guadalajara, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Atención Primaria de Guadalajara, Guadalajara</wicri:regionArea><wicri:noRegion>Guadalajara</wicri:noRegion></affiliation></author><author><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia y microbiólogo clínico, Miembro del Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia y microbiólogo clínico, Miembro del Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Valdeperez, J" sort="Valdeperez, J" uniqKey="Valdeperez J" first="J" last="Valdepérez">J. Valdepérez</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Centro de Salud Actur Sur, Zaragoza, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Salud Actur Sur, Zaragoza</wicri:regionArea><wicri:noRegion>Zaragoza</wicri:noRegion></affiliation></author><author><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><affiliation wicri:level="3"><nlm:affiliation>Especialista en Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Especialista en Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Centro de Atención Primaria Francia, Fuenlabrada, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><affiliation wicri:level="3"><nlm:affiliation>Médico de Familia, Responsable Grupo de Trabajo Vacunas SEMG, Centro de Salud Isla de Oza, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Responsable Grupo de Trabajo Vacunas SEMG, Centro de Salud Isla de Oza, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><affiliation wicri:level="1"><nlm:affiliation>Médico de Familia, Miembro del Grupo de Respiratorio SEMG, Centro de Salud Algeciras Norte, Algeciras, Cádiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Médico de Familia, Miembro del Grupo de Respiratorio SEMG, Centro de Salud Algeciras Norte, Algeciras, Cádiz</wicri:regionArea><wicri:noRegion>Cádiz</wicri:noRegion></affiliation></author><author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><affiliation wicri:level="1"><nlm:affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña</wicri:regionArea><wicri:noRegion>A Coruña</wicri:noRegion></affiliation></author></analytic><series><title level="j">Semergen</title><idno type="eISSN">1578-8865</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Community-Acquired Infections (prevention & control)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Mass Vaccination (methods)</term><term>Middle Aged (MeSH)</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Pneumonia, Pneumococcal (prevention & control)</term><term>Pneumonia, Viral (prevention & control)</term><term>Seasons (MeSH)</term><term>Spain (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Espagne (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Infections communautaires (prévention et contrôle)</term><term>Jeune adulte (MeSH)</term><term>Pneumonie à pneumocoques (prévention et contrôle)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Saisons (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Vaccination de masse (méthodes)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antipneumococciques (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Vaccination</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Vaccination de masse</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Community-Acquired Infections</term><term>Influenza, Human</term><term>Pneumonia, Pneumococcal</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term><term>Infections communautaires</term><term>Pneumonie à pneumocoques</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Humans</term><term>Middle Aged</term><term>Seasons</term><term>Spain</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Espagne</term><term>Humains</term><term>Jeune adulte</term><term>Saisons</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults. The annual incidence of CAP in adults in Spain ranges from 3 to 14 cases per 1,000 inhabitants. Current clinical guidelines primarily focus on the therapeutic approach to CAP rather than its prevention. The aim of this study is to develop and propose a practical guide for CAP prevention through vaccination in Spain according to available vaccines and evidence.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>A literature review and expert opinion.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Pneumococcal and influenza vaccines are the main preventive tools available against CAP. Age, chronic diseases, and immunosuppression are risk factors for pneumonia, so these populations should be a priority for vaccination. In addition, influenza and pneumococcal vaccination is considered advisable in healthy adults under 60 years of age, and anyone with risk condition for CAP, irrespective of age. The influenza vaccine will be administered seasonally, while pneumococcal vaccination can be administered at any time of the year.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Vaccination against pneumococcus and influenza in adults can help to reduce the burden of CAP and its associated complications. The available evidence supports the priority indications set out in this guide, and it would be advisable to try to achieve a wide circulation and practical implementation of these recommendations.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27641310</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>7</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].</ArticleTitle><Pagination><MedlinePgn>464-475</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(16)30141-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2016.07.009</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults. The annual incidence of CAP in adults in Spain ranges from 3 to 14 cases per 1,000 inhabitants. Current clinical guidelines primarily focus on the therapeutic approach to CAP rather than its prevention. The aim of this study is to develop and propose a practical guide for CAP prevention through vaccination in Spain according to available vaccines and evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature review and expert opinion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Pneumococcal and influenza vaccines are the main preventive tools available against CAP. Age, chronic diseases, and immunosuppression are risk factors for pneumonia, so these populations should be a priority for vaccination. In addition, influenza and pneumococcal vaccination is considered advisable in healthy adults under 60 years of age, and anyone with risk condition for CAP, irrespective of age. The influenza vaccine will be administered seasonally, while pneumococcal vaccination can be administered at any time of the year.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vaccination against pneumococcus and influenza in adults can help to reduce the burden of CAP and its associated complications. The available evidence supports the priority indications set out in this guide, and it would be advisable to try to achieve a wide circulation and practical implementation of these recommendations.</AbstractText><CopyrightInformation>Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Redondo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Médico de Familia, Coordinadora del Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivero</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Médico de Familia, Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascarós</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Médico de Familia, Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díaz-Maroto</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Médico de Familia, Centro de Atención Primaria de Guadalajara, Guadalajara, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linares</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Médico de Familia y microbiólogo clínico, Miembro del Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdepérez</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Médico de Familia, Centro de Salud Actur Sur, Zaragoza, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Especialista en Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Médico de Familia, Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimeno</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Médico de Familia, Responsable Grupo de Trabajo Vacunas SEMG, Centro de Salud Isla de Oza, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocaña</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Médico de Familia, Miembro del Grupo de Respiratorio SEMG, Centro de Salud Algeciras Norte, Algeciras, Cádiz, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinón-Torres</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pediatra, Departamento de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España; Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>en nombre de NEUMOEXPERTOS EN PREVENCIÓN</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del Grupo de Neumoexpertos en Prevención.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Community-acquired pneumonia</Keyword><Keyword MajorTopicYN="Y">Flu vaccination, Pneumococcal conjugate vaccine, Pneumococcal Polysaccharide Vaccine</Keyword><Keyword MajorTopicYN="Y">Neumonía adquirida en la comunidad</Keyword><Keyword MajorTopicYN="Y">Vacuna antineumocócica conjugada</Keyword><Keyword MajorTopicYN="Y">Vacuna antineumocócica polisacárida</Keyword><Keyword MajorTopicYN="Y">Vacunación antigripal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27641310</ArticleId><ArticleId IdType="pii">S1138-3593(16)30141-1</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2016.07.009</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name></region><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><name sortKey="Rivero, I" sort="Rivero, I" uniqKey="Rivero I" first="I" last="Rivero">I. Rivero</name><name sortKey="Valdeperez, J" sort="Valdeperez, J" uniqKey="Valdeperez J" first="J" last="Valdepérez">J. Valdepérez</name><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000116 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000116 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27641310
|texte= [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27641310" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |